Ming-Hui Zhao Selected Research

Diabetes Mellitus

8/2021	Clinical significance of single and persistent elevation of serum high-sensitivity C-reactive protein levels for prediction of kidney outcomes in patients with impaired fasting glucose or diabetes mellitus.
2/2018	P66Shc expression in diabetic rat retina.
2/2018	Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Hui Zhao Research Topics

Disease

68	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2024 - 10/2005
58	Vasculitis (Vasculitides) 04/2024 - 05/2004
46	Glomerulonephritis 05/2024 - 07/2005
38	Proteinuria 03/2023 - 02/2007
34	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 03/2024 - 07/2005
29	Lupus Nephritis 11/2023 - 01/2005
29	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2023 - 06/2010
20	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 09/2004
17	Chronic Renal Insufficiency 04/2024 - 10/2016
14	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 06/2009
14	Microscopic Polyangiitis 09/2020 - 04/2006
12	Inflammation (Inflammations) 12/2023 - 07/2005
12	Kidney Diseases (Kidney Disease) 06/2023 - 02/2018
11	Hemorrhage 03/2024 - 06/2009
10	Infections 04/2024 - 01/2014
10	Nephritis 01/2024 - 01/2005
10	IGA Glomerulonephritis (IGA Nephropathy) 11/2023 - 01/2005
9	Fibrosis (Cirrhosis) 12/2023 - 01/2007
9	Neoplasms (Cancer) 09/2023 - 12/2015
9	Diabetic Nephropathies (Diabetic Nephropathy) 08/2023 - 01/2020
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 10/2005
9	Renal Insufficiency (Renal Failure) 01/2021 - 06/2009
8	Hypertension (High Blood Pressure) 02/2022 - 12/2007
8	Systemic Vasculitis 09/2020 - 04/2006
8	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 09/2020 - 04/2006
7	Thrombotic Microangiopathies 12/2023 - 01/2010
7	Amyloidosis 01/2022 - 01/2011
7	Wounds and Injuries (Trauma) 01/2022 - 04/2016
6	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 09/2004
6	Atrophy 12/2023 - 01/2007
6	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 05/2023 - 01/2008
6	Hematuria 01/2020 - 01/2005
5	Nephrotic Syndrome (Syndrome, Nephrotic) 06/2023 - 02/2007
5	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 05/2023 - 01/2008
5	Disease Progression 01/2023 - 01/2016
4	Albuminuria 05/2024 - 09/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
4	Paraproteinemias (Monoclonal Gammopathy) 12/2019 - 10/2018
3	Oliguria 09/2023 - 01/2007
3	Anuria 09/2023 - 01/2007
3	Acute Tubulointerstitial Nephritis 05/2023 - 11/2019
3	Amyloid Plaque 01/2022 - 12/2019
3	Multiple Myeloma 08/2021 - 11/2018
3	Diabetes Mellitus 08/2021 - 02/2018
3	Purpura 06/2020 - 01/2010
3	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 01/2017
3	Interstitial Nephritis (Tubulointerstitial Nephritis) 11/2019 - 01/2011

Drug/Important Bio-Agent (IBA)

91	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2024 - 05/2004
55	AntibodiesIBA 03/2024 - 01/2005
50	CreatinineIBA 04/2024 - 09/2004
43	AutoantibodiesIBA 12/2023 - 01/2005
29	Immunoglobulin G (IgG)IBA 12/2023 - 10/2005
28	Complement System Proteins (Complement)IBA 12/2023 - 01/2005
24	Peroxidase (Myeloperoxidase)IBA 09/2020 - 10/2005
22	antiglomerular basement membrane antibodyIBA 03/2024 - 07/2005
18	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2005
17	EpitopesIBA 01/2023 - 06/2009
15	AntigensIBA 11/2023 - 05/2004
14	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 01/2005
13	Peptides (Polypeptides)IBA 01/2023 - 06/2015
11	Antigen-Antibody Complex (Immune Complex)IBA 05/2024 - 01/2006
11	Complement Factor H (Factor H)IBA 10/2023 - 05/2015
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2007
10	Phospholipase A2 ReceptorsIBA 03/2023 - 05/2017
10	Propylthiouracil FDA Link 03/2016 - 10/2005
9	AlbuminsIBA 05/2024 - 05/2016
9	C-Reactive ProteinIBA 04/2024 - 01/2011
9	Hemoglobins (Hemoglobin)IBA 07/2023 - 12/2009
8	AutoantigensIBA 01/2023 - 01/2011
7	Rituximab (Mabthera)FDA Link 12/2022 - 01/2018
7	HMGB1 Protein (HMG1)IBA 01/2020 - 01/2015
6	EnzymesIBA 11/2023 - 08/2010
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 09/2011
6	HLA-DRB1 Chains (HLA DRB1)IBA 01/2020 - 11/2009
6	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 09/2011
5	Immunoglobulin A (IgA)IBA 11/2023 - 07/2005
5	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 12/2022 - 01/2014
5	Serum AlbuminIBA 08/2021 - 05/2017
5	Immunoglobulin M (IgM)IBA 01/2020 - 01/2006
5	Amino Acids FDA Link 10/2019 - 05/2011
4	CollagenIBA 12/2023 - 12/2016
4	Uric Acid (Urate)IBA 12/2023 - 02/2020
4	ImmunosorbentsIBA 11/2023 - 07/2014
4	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 02/2018
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 05/2011
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 05/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2006
3	anti-glomerular basement membrane autoantibodyIBA 11/2023 - 12/2009
3	Complement C3a (Complement 3a)IBA 01/2022 - 01/2017
3	Annexin A1IBA 01/2022 - 01/2021
3	Streptozocin (Streptozotocin)FDA Link 10/2021 - 02/2018
3	HDL LipoproteinsIBA 08/2021 - 05/2017
3	MercuryIBA 03/2021 - 01/2019

Therapy/Procedure

21	Therapeutics 11/2023 - 08/2010
6	Renal Replacement Therapy (Therapies, Renal Replacement) 03/2024 - 11/2018
3	Length of Stay 03/2024 - 01/2022
3	Renal Dialysis (Hemodialysis) 07/2023 - 06/2009
3	Lasers (Laser) 01/2022 - 01/2011
3	Transplantation 12/2020 - 01/2020
3	Plasmapheresis 01/2020 - 09/2011